Insider · CIK 0001916987

Brady James Aloysius

Reports to the SEC for 2 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001916987

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33K sh	$6.15	+$203K	32,996
2026-06-04	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+24.2K sh	—	—	113,359
2026-03-30	XERSXeris Biopharma Holdings, Inc.S Sale	Director	SSale	−10.8K sh	$5.54	−$60K	89,166
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director	MExercise/Conversion	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−288K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−96K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−240K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+72K sh	—	—	72,000
2025-08-01	VRNAVerona Pharma plcS Sale	Director	SSale	−824 sh	$13.14	−$10.8K	23,176
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−24K sh	—	—	72,000
2025-08-01	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+24K sh	—	—	24,000
2025-04-25	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Director	AAward	+96K sh	—	—	96,000
2025-03-28	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+100K sh	—	—	100,000
2024-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+240K sh	—	—	240,000
2023-04-28	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+96K sh	—	—	96,000
2022-03-14	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+288K sh	—	—	288,000

Recent filings

Accepted (ET)
Jun 54
Brady James Aloysius0001916987-26-000004
SEC(opens sec.gov)
Apr 14
Brady James Aloysius0001916987-26-000002
SEC(opens sec.gov)
Oct 84
Brady James Aloysius0001104659-25-097946
SEC(opens sec.gov)
Aug 54
Brady James Aloysius0001104659-25-074391
SEC(opens sec.gov)
Apr 294
Brady James Aloysius0001104659-25-041387
SEC(opens sec.gov)
Mar 284
Brady James Aloysius0001867096-25-000058
SEC(opens sec.gov)
Apr 304
Brady James Aloysius0001104659-24-054942
SEC(opens sec.gov)
Apr 284
Brady James Aloysius0001104659-23-052990
SEC(opens sec.gov)
Mar 164
Brady James Aloysius0001104659-22-034156
SEC(opens sec.gov)

Companies

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607